201 related articles for article (PubMed ID: 12210541)
1. Approaches to the assessment of toxicity data with endpoints related to endocrine disruption.
Harvey PW; Johnson I
J Appl Toxicol; 2002; 22(4):241-7. PubMed ID: 12210541
[TBL] [Abstract][Full Text] [Related]
2. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
3. Uncertainties for endocrine disrupters: our view on progress.
Daston GP; Cook JC; Kavlock RJ
Toxicol Sci; 2003 Aug; 74(2):245-52. PubMed ID: 12730617
[TBL] [Abstract][Full Text] [Related]
4. The adrenal cortex and steroidogenesis as cellular and molecular targets for toxicity: critical omissions from regulatory endocrine disrupter screening strategies for human health?
Harvey PW; Everett DJ
J Appl Toxicol; 2003; 23(2):81-7. PubMed ID: 12666151
[TBL] [Abstract][Full Text] [Related]
5. Adrenal toxicology: a strategy for assessment of functional toxicity to the adrenal cortex and steroidogenesis.
Harvey PW; Everett DJ; Springall CJ
J Appl Toxicol; 2007; 27(2):103-15. PubMed ID: 17265431
[TBL] [Abstract][Full Text] [Related]
6. FIFRA Subdivision F testing Guidelines: are these tests adequate to detect potential hormonal activity for crop protection chemicals? Federal Insecticide, Fungicide, and Rodenticide Act.
Stevens JT; Tobia A; Lamb JC; Tellone C; O'Neal F
J Toxicol Environ Health; 1997 Apr; 50(5):415-31. PubMed ID: 9140462
[TBL] [Abstract][Full Text] [Related]
7. Current and potential rodent screens and tests for thyroid toxicants.
Zoeller RT; Tyl RW; Tan SW
Crit Rev Toxicol; 2007; 37(1-2):55-95. PubMed ID: 17364705
[TBL] [Abstract][Full Text] [Related]
8. The enhancement of the subacute repeat dose toxicity test OECD TG 407 for the detection of endocrine active chemicals: comparison with toxicity tests of longer duration.
Gelbke HP; Hofmann A; Owens JW; Freyberger A
Arch Toxicol; 2007 Apr; 81(4):227-50. PubMed ID: 17047927
[TBL] [Abstract][Full Text] [Related]
9. Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing.
Thybaud V; Aardema M; Clements J; Dearfield K; Galloway S; Hayashi M; Jacobson-Kram D; Kirkland D; MacGregor JT; Marzin D; Ohyama W; Schuler M; Suzuki H; Zeiger E;
Mutat Res; 2007 Feb; 627(1):41-58. PubMed ID: 17126066
[TBL] [Abstract][Full Text] [Related]
10. Multi-criteria decision analysis of test endpoints for detecting the effects of endocrine active substances in fish full life cycle tests.
Crane M; Gross M; Matthiessen P; Ankley GT; Axford S; Bjerregaard P; Brown R; Chapman P; Dorgeloh M; Galay-Burgos M; Green J; Hazlerigg C; Janssen J; Lorenzen K; Parrott J; Rufli H; Schäfers C; Seki M; Stolzenberg HC; van der Hoeven N; Vethaak D; Winfield IJ; Zok S; Wheeler J
Integr Environ Assess Manag; 2010 Jul; 6(3):378-89. PubMed ID: 20821701
[TBL] [Abstract][Full Text] [Related]
11. Final amended report on the safety assessment of Methylparaben, Ethylparaben, Propylparaben, Isopropylparaben, Butylparaben, Isobutylparaben, and Benzylparaben as used in cosmetic products.
Int J Toxicol; 2008; 27 Suppl 4():1-82. PubMed ID: 19101832
[TBL] [Abstract][Full Text] [Related]
12. Assessment of in vivo assays for endocrine disruption.
Clode SA
Best Pract Res Clin Endocrinol Metab; 2006 Mar; 20(1):35-43. PubMed ID: 16522518
[TBL] [Abstract][Full Text] [Related]
13. Use of the laboratory rat as a model in endocrine disruptor screening and testing.
Gray LE; Wilson V; Noriega N; Lambright C; Furr J; Stoker TE; Laws SC; Goldman J; Cooper RL; Foster PM
ILAR J; 2004; 45(4):425-37. PubMed ID: 15454681
[TBL] [Abstract][Full Text] [Related]
14. Selecting appropriate animal models and experimental designs for endocrine disruptor research and testing studies.
Stokes WS
ILAR J; 2004; 45(4):387-93. PubMed ID: 15454677
[TBL] [Abstract][Full Text] [Related]
15. Effects of pyrethroids on voltage-sensitive calcium channels: a critical evaluation of strengths, weaknesses, data needs, and relationship to assessment of cumulative neurotoxicity.
Shafer TJ; Meyer DA
Toxicol Appl Pharmacol; 2004 Apr; 196(2):303-18. PubMed ID: 15081275
[TBL] [Abstract][Full Text] [Related]
16. Strengths and limitations of using repeat-dose toxicity studies to predict effects on fertility.
Dent MP
Regul Toxicol Pharmacol; 2007 Aug; 48(3):241-58. PubMed ID: 17512650
[TBL] [Abstract][Full Text] [Related]
17. Factors considered in using birds for evaluating endocrine-disrupting chemicals.
Touart LW
ILAR J; 2004; 45(4):462-8. PubMed ID: 15454685
[TBL] [Abstract][Full Text] [Related]
18. In vitro models in endocrine disruptor screening.
Charles GD
ILAR J; 2004; 45(4):494-501. PubMed ID: 15454688
[TBL] [Abstract][Full Text] [Related]
19. Use of the dog as non-rodent test species in the safety testing schedule associated with the registration of crop and plant protection products (pesticides): present status.
Box RJ; Spielmann H
Arch Toxicol; 2005 Nov; 79(11):615-26. PubMed ID: 15940470
[TBL] [Abstract][Full Text] [Related]
20. Implications of research on assays to characterize thyroid toxicants.
Zoeller RT; Tan SW
Crit Rev Toxicol; 2007; 37(1-2):195-210. PubMed ID: 17364709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]